NEW YORK (GenomeWeb News) – EpiVax's immunogenicity screening technology will be incorporated into BioAtla's antibody Express Humanization platform under a collaboration announced today.
In a recent interview with ProteoMonitor, Swiss Federal Institute of Technology Zurich researcher Ruedi Aebersold observed that to a significant extent, proteomics has been constrained by a lack of good affinity reagents (
NEW YORK (GenomeWeb News) – Research reagents company Rockland Immunochemicals today said it has purchased the Epi-Plus antibody product line from 21st Century Biochemicals for an undisclosed amount.
NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.
NEW YORK (GenomeWeb News) - Bio-Rad Laboratories said today that it has closed its acquisition of antibody manufacturer AbD Serotec, a division of MorphoSys, for around €53 million ($70 million) in cash.
NEW YORK (GenomeWeb News) – Bio-Rad Laboratories announced yesterday that it has signed a definitive agreement to acquire antibody manufacturer AbD Serotec for €53 million ($69.7 million) in cash.
NEW YORK (GenomeWeb News) – LifeMap Sciences today announced an exclusive distribution deal with ProSpec-Tany TechnoGene to offer more than 1,000 recombinant proteins and antibodies.
Arrowhead Research said this week that it has signed a deal under which an undisclosed Merck subsidiary will evaluate a novel therapeutic monoclonal antibody candidate developed through its human-derived peptide targeting and discovery program.
NEW YORK (GenomeWeb News) – Life Technologies has struck a collaborative partnership with the Structural Genomics Consortium to develop and release 200 highly specific epigenetic recombinant antibodies, the company said today.
The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.
